LLS makes progress for blood cancer patients through virtual advocacy By Brianna Wilson, Senior Manager, Advocacy Communications | July 15, 2021 Read More
Highlights from ASCO 2021 By Lee Greenberger, PhD, LLS Chief Scientific Officer | June 17, 2021 The 2021 American Society of Clinical Oncology (ASCO) Annual Meeting took place last week. Read More
Because You Volunteer, Your Impact Creates a Ripple Effect By Teri Johnson, Senior Vice President, Volunteer Engagement at LLS | April 19, 2021 Read More
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma By Lee Greenberger, PhD, Chief Scientific Officer at LLS | March 27, 2021 Read More
FDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a Welcome Step Forward By Gwen Nichols, MD, LLS Chief Medical Officer | March 31, 2021 Read More
Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma By Lee Greenberger, PhD, Chief Scientific Officer at LLS | March 5, 2021 Read More
Meet Three Women in Science Championing Myeloma Cures and Care By LLS Staff | March 5, 2021 Read More
